The US Preventive Services Task Force (USPSTF) has recommended against routine prostate-specific antigen (PSA)–based prostate cancer (PCa) screening, initially for men older than 75 years in 2008, and then for all men in 2012. This evidence concerns the gene KLK3 and prostate cancer.